mRNA for Tissue-Type Plasminogen Activator Is Present in Lesional Epidermis from Patients with Psoriasis, Pemphigus, or Bullous Pemphigoid, But Is Not Detected in Normal Epidermis

Autor: Gerald S. Lazarus, Pamela J. Jensen, Janet Baird, Dominique Belin, Nathalie Busso, Pascale Gubler, Jean-Dominique Vassalli
Rok vydání: 1990
Předmět:
Keratinocytes
Pathology
medicine.medical_specialty
Plasmin
Biopsy
Gene Expression
Pemphigoid
Bullous/ metabolism/pathology

Dermatology
Plasminogen Activators/genetics/metabolism
Biochemistry
Plasminogen Activators
Keratinocytes/metabolism
Tissue Plasminogen Activator/ genetics/metabolism
Fibrinolytic Agents
Pemphigus/ metabolism/pathology
Psoriasis
Fibrinolytic Agents/metabolism
Pemphigoid
Bullous

medicine
Humans
Northern blot
RNA
Messenger

Molecular Biology
Cells
Cultured

ddc:616
Messenger RNA
Epidermis/chemistry/ metabolism/pathology
Psoriasis/ metabolism/pathology
Epidermis (botany)
integumentary system
business.industry
Cell Biology
medicine.disease
Blotting
Northern

Urokinase-Type Plasminogen Activator
Pemphigus
Tissue Plasminogen Activator
Immunology
Bullous pemphigoid
Epidermis
Urokinase-Type Plasminogen Activator/genetics/metabolism
business
RNA
Messenger/analysis/genetics/ metabolism

Plasminogen activator
medicine.drug
Zdroj: Journal of Investigative Dermatology, Vol. 95, No 5 (1990) pp. 548-552
ISSN: 0022-202X
DOI: 10.1111/1523-1747.ep12504901
Popis: Plasminogen activator (PA), which catalyzes the conversion of plasminogen to the proteinase plasmin, has been implicated in a variety of cutaneous disorders. Lesional epidermis from patients with psoriasis, pemphigus, bullous pemphigoid, and Hailey-Hailey disease contains elevated levels of tissue-type PA (tPA) activity compared to non-lesional epidermis or to epidermis from normal individuals. In the present study, we have used Northern blot analysis to demonstrate that mRNA for tPA is detectable in lesions from patients with psoriasis, pemphigus, and bullous pemphigoid, but is not detectable in normal epidermis. These data strongly suggest that the tPA enzymatic activity present in lesional epidermis results from enhanced synthesis of the enzyme in situ, secondary to elevated steady-state levels of tPA mRNA. Cultured keratinocytes likewise are shown to contain tPA mRNA. Previous investigators have suggested that the phenotypes of keratinocytes in culture, psoriatic epidermis, and epidermis in the process of wound reepithelialization are comparable. Our findings, combined with those of other investigators, suggest that elevated tPA expression may be another common feature of epidermis under these circumstances.
Databáze: OpenAIRE